These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38645066)

  • 1. Nor-LAAM loaded PLGA Microparticles for Treating Opioid Use Disorder.
    Ingabire D; Qin C; Meng T; Raynold AAM; Sudarjat H; Townsend EA; Pangeni R; Poudel S; Arriaga M; Zhao L; Chow WN; Banks M; Xu Q
    bioRxiv; 2024 Apr; ():. PubMed ID: 38645066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nor-LAAM loaded PLGA microparticles for treating opioid use disorder.
    Ingabire D; Qin C; Meng T; Raynold AAM; Sudarjat H; Townsend EA; Pangeni R; Poudel S; Arriaga M; Zhao L; Chow WN; Banks M; Xu Q
    J Control Release; 2024 Sep; 373():93-104. PubMed ID: 38968971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experiences with 959 opioid-dependent patients treated with levo-alpha-acetylmethadol (LAAM).
    Tennant FS; Rawson RA; Pumphrey E; Seecof R
    J Subst Abuse Treat; 1986; 3(3):195-202. PubMed ID: 3806733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levo-alpha-acetylmethadol (LAAM): clinical, research, and policy issues of a new pharmacotherapy for opioid addiction.
    Prendergast ML; Grella C; Perry SM; Anglin MD
    J Psychoactive Drugs; 1995; 27(3):239-47. PubMed ID: 8594167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction.
    Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N
    Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of methadone and levo-alpha-acetylmethadol (LAAM) by human intestinal cytochrome P450 3A4 (CYP3A4): potential contribution of intestinal metabolism to presystemic clearance and bioactivation.
    Oda Y; Kharasch ED
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1021-32. PubMed ID: 11504799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of levo-alpha-acetylmethadol (LAAM) on morphine self-administration in the rat.
    Lukas SE; Moreton JE; Khazan N
    Psychopharmacology (Berl); 1981; 73(1):12-6. PubMed ID: 6785783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of levo-alpha-Acetylmethadol (LAAM) by human liver cytochrome P450: involvement of CYP3A4 characterized by atypical kinetics with two binding sites.
    Oda Y; Kharasch ED
    J Pharmacol Exp Ther; 2001 Apr; 297(1):410-22. PubMed ID: 11259570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical role of cytochrome P450 3A in the bioactivation and clinical effects of levo-alpha-acetylmethadol: importance of clinical investigations to validate in vitro drug metabolism studies.
    Kharasch ED; Whittington D; Hoffer C; Krudys K; Craig K; Vicini P; Sheffels P; Lalovic B
    Clin Pharmacokinet; 2005; 44(7):731-51. PubMed ID: 15966756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of biodegradable poly(malate) and poly(lactic-co-glycolic acid) microparticles with low molecular polyethylene glycol.
    Yoncheva K; Lambov N; Miloshev S
    Drug Dev Ind Pharm; 2009 Apr; 35(4):449-54. PubMed ID: 19288298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental toxicity of levo-alpha-acetylmethadol (LAAM) in tolerant rats.
    York RG; Denny KH; Moody DE; Alburges ME
    Int J Toxicol; 2002; 21(2):147-59. PubMed ID: 12022632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response analysis of opioid cross-tolerance and withdrawal suppression during LAAM maintenance.
    Houtsmuller EJ; Walsh SL; Schuh KJ; Johnson RE; Stitzer ML; Bigelow GE
    J Pharmacol Exp Ther; 1998 May; 285(2):387-96. PubMed ID: 9580575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of uniform fenofibrate-loaded biodegradable microparticle by membrane emulsification.
    Meng T; Sudarjat H; Momin M; Ma JX; Xu Q
    Int J Pharm; 2024 Jan; 650():123675. PubMed ID: 38061500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions.
    Eissenberg T; Stitzer ML; Bigelow GE; Buchhalter AR; Walsh SL
    J Pharmacol Exp Ther; 1999 May; 289(2):936-45. PubMed ID: 10215673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evaluation of solid lipid microparticles and hybrid polymer-lipid microparticles for sustained delivery of leuprolide.
    Wu C; Luo X; Baldursdottir SG; Yang M; Sun X; Mu H
    Eur J Pharm Biopharm; 2019 Sep; 142():315-321. PubMed ID: 31299277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levo-alpha-acetylmethadol (LAAM) induced QTc-prolongation - results from a controlled clinical trial.
    Wieneke H; Conrads H; Wolstein J; Breuckmann F; Gastpar M; Erbel R; Scherbaum N
    Eur J Med Res; 2009 Jan; 14(1):7-12. PubMed ID: 19258204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
    Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
    Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis.
    Newcombe DA; Bochner F; White JM; Somogyi AA
    Drug Alcohol Depend; 2004 Oct; 76(1):63-72. PubMed ID: 15380290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine.
    Ling W; Rawson RA; Compton MA
    J Psychoactive Drugs; 1994; 26(2):119-28. PubMed ID: 7931856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in sensitivity to the rate-decreasing effects of opioids in pigeons treated acutely or chronically with l-alpha-acetylmethadol.
    Gerak LR; France CP
    J Pharmacol Exp Ther; 1997 May; 281(2):799-809. PubMed ID: 9152388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.